TEVA (TEVA)
Teva Pharmaceutical Industries Ltd. - Teva Expands European biosimilars portfolio with launchof AHZANTIVE® (aflibercept) biosimilar toEylea®
Teva Pharmaceutical Industries Ltd. - Teva Expands European biosimilars portfolio with launchof AHZANTIVE® (aflibercept) biosimilar toEylea®
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General